Tracking LRRK2-Parkinson’s Progression for Better Trial Design
Parkinson’s disease comes in many flavors, posing a challenge for clinical trials. Knowing how the disease progresses may improve chances of success. A longitudinal study from the LRRK2 Ashkenazi Jewish Consortium provides just such data.










